Given its significant role in DNA repair and its association with various cancers, NBS1 has the potential to serve as a biomarker for cancer diagnosis and prognosis. The expression levels of NBS1 could be used to predict disease outcomes or the likelihood of response to certain therapies, especially those that target DNA repair pathways. However, further research is needed to validate NBS1 as a reliable biomarker in clinical settings.
